Stock 300519 ZHEJIANG XINGUANG PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Zhejiang Xinguang Pharmaceutical Co., Ltd.

Equities

300519

CNE1000027T3

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 18:00:00 2024-06-20 EDT 		5-day change 1st Jan Change
11.01 CNY +1.01% Intraday chart for Zhejiang Xinguang Pharmaceutical Co., Ltd. -2.13% -33.55%
05-22 Zhejiang Xinguang Pharmaceutical Co., Ltd. Announces Final Cash Dividend Plan on A Shares for the Year 2023, Payable on 29 May 2024 CI
05-20 Zhejiang Xinguang Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 2,213 2,168 2,558 3,230 2,506 2,651
Enterprise Value (EV) 1 1,628 1,543 1,882 2,512 1,769 1,952
P/E ratio 25.1 x 23 x 25.8 x 28.4 x 23 x 41.4 x
Yield 2.17% 3.32% 3.75% 2.97% 3.19% 2.41%
Capitalization / Revenue 8.01 x 7.44 x 9.04 x 10.1 x 7.13 x 9.8 x
EV / Revenue 5.89 x 5.3 x 6.65 x 7.83 x 5.03 x 7.22 x
EV / EBITDA 17.5 x 15.1 x 18.1 x 20.7 x 14.2 x 30.6 x
EV / FCF 39.7 x 32 x 27.3 x 28.6 x 24.6 x 275 x
FCF Yield 2.52% 3.13% 3.66% 3.5% 4.06% 0.36%
Price to Book 2.94 x 2.71 x 3.09 x 3.82 x 2.92 x 3.14 x
Nbr of stocks (in thousands) 160,000 160,000 160,000 160,000 160,000 160,000
Reference price 2 13.83 13.55 15.99 20.19 15.66 16.57
Announcement Date 19-04-18 20-04-20 21-04-26 22-04-18 23-04-24 24-04-21
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 276.3 291.3 283.1 320.9 351.5 270.4
EBITDA 1 93.2 102.3 104.2 121.6 124.9 63.71
EBIT 1 85.34 92.09 91.69 108.7 110.8 48.93
Operating Margin 30.89% 31.62% 32.39% 33.89% 31.53% 18.1%
Earnings before Tax (EBT) 1 100.9 108.3 114.8 132 125.6 73.16
Net income 1 88 93.9 98.98 114.3 108.8 64.36
Net margin 31.85% 32.24% 34.96% 35.62% 30.96% 23.8%
EPS 2 0.5500 0.5900 0.6200 0.7100 0.6800 0.4000
Free Cash Flow 1 41.01 48.26 68.95 87.82 71.83 7.094
FCF margin 14.84% 16.57% 24.36% 27.37% 20.44% 2.62%
FCF Conversion (EBITDA) 43.99% 47.18% 66.16% 72.22% 57.52% 11.13%
FCF Conversion (Net income) 46.6% 51.4% 69.67% 76.84% 66.01% 11.02%
Dividend per Share 2 0.3000 0.4500 0.6000 0.6000 0.5000 0.4000
Announcement Date 19-04-18 20-04-20 21-04-26 22-04-18 23-04-24 24-04-21
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 584 625 677 719 737 699
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 41 48.3 69 87.8 71.8 7.09
ROE (net income / shareholders' equity) 12.1% 12.1% 12.2% 13.7% 12.8% 7.56%
ROA (Net income/ Total Assets) 6.68% 6.84% 6.54% 7.45% 7.33% 3.24%
Assets 1 1,318 1,373 1,513 1,533 1,485 1,987
Book Value Per Share 2 4.710 5.000 5.170 5.290 5.370 5.280
Cash Flow per Share 2 2.540 2.550 3.700 3.710 3.890 3.400
Capex 1 21.3 16 10.3 14.7 16.6 16
Capex / Sales 7.7% 5.49% 3.63% 4.59% 4.74% 5.91%
Announcement Date 19-04-18 20-04-20 21-04-26 22-04-18 23-04-24 24-04-21
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Alternative Medicine

1st Jan change Capi.
ZHEJIANG XINGUANG PHARMACEUTICAL CO., LTD. Stock Zhejiang Xinguang Pharmaceutical Co., Ltd.
-33.55% 243M
DONG-E-E-JIAO CO.,LTD. Stock Dong-E-E-Jiao Co.,Ltd.
+34.14% 5.87B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd.
-30.04% 3.71B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
+1.55% 3.17B
TASLY PHARMACEUTICAL GROUP CO., LTD Stock Tasly Pharmaceutical Group Co., Ltd
-22.68% 2.71B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. Stock Shandong Buchang Pharmaceuticals Co., Ltd.
-8.17% 2.36B
HENAN LINGRUI PHARMACEUTICAL CO., LTD. Stock Henan Lingrui Pharmaceutical Co., Ltd.
+42.02% 1.89B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD Stock Zhejiang Jolly Pharmaceutical Co.,LTD
+45.22% 1.5B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. Stock Tibet Cheezheng Tibetan Medicine Co., Ltd.
-12.58% 1.44B
PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK Stock PT Industri Jamu dan Farmasi Sido Muncul Tbk
+40.95% 1.35B
Alternative Medicine
  1. Stock Market
  2. Equities
  3. 300519 Stock
  4. Financials Zhejiang Xinguang Pharmaceutical Co., Ltd.